U.S. markets open in 5 hours 19 minutes

Castlight Health, Inc. (CSLT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
1.7000-0.0300 (-1.73%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Previous Close1.7300
Bid0.0000 x 1300
Ask0.0000 x 2200
Day's Range1.6900 - 1.7600
52 Week Range0.7700 - 2.7100
Avg. Volume687,112
Market Cap272.428M
Beta (5Y Monthly)1.84
PE Ratio (TTM)N/A
EPS (TTM)-0.0450
Earnings DateNov 02, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.97
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for CSLT

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Castlight Health, Inc.
    Technical Assessment: Bullish in the Intermediate-TermAs we have noted recently, there has been a sharp increase in Treasury yields across the entire yield curve. At the start of September, two-year notes were yielding 0.2%. As of the close on Monday, they were at 0.44%. The five-year note has risen from 0.78% to 1.16%, the 10-year bond has jumped from 1.31% to 1.64%, and the 30-year bond has popped from 1.92% to 2.09%. Both the two- and five-year note yields are at their highest since the pandemic began, when yields plummeted. As we have said, market rates are a great tell as generally they move before government rates (fed funds) do.
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more